ATOSSA THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Other
ATOSSA THERAPEUTICS, INC. (ATOS) reported Adjustments to Additional Paid in Capital, Other of -$42.86 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2018-03-08
- ATOSSA THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2016-12-31 was -$16.39K.
- ATOSSA THERAPEUTICS, INC. adjustments to additional paid in capital, other for the quarter ending 2016-09-30 was -$19.85K.
- ATOSSA THERAPEUTICS, INC. adjustments to additional paid in capital, other for fiscal 2016 was -$42.86K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$16.39K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-08 | -$36.25K derived: sum of 2 quarters · filed 2018-03-08 | -$42.86K 10-K · filed 2018-03-08 | |
| 2016-09-30 | -$19.85K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$26.47K 10-Q/A · filed 2017-03-21 | ||
| 2016-06-30 | -$6.62K 10-Q/A · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |